Investigating Risk Factors
Memorial Sloan-Kettering Cancer Center established a Familial Pancreatic Cancer Registry in 2002 to learn more about what causes some people to be at increased risk for pancreatic cancer, and to develop better screening tools for high-risk individuals. The registry enrolls the first-degree relatives (parent, sibling, or child) of patients who were diagnosed with pancreatic cancer before age 50. It also includes people thought to be at high risk for the disease based on its diagnosis in multiple first- or second-degree relatives, as well as people with BRCA1 or BRCA2 mutations who also have a family history of pancreatic cancer.
Participants who are considered at high risk are screened yearly using MRI to look for lesions that can develop into tumors, including intraductal papillary mucinous neoplasms (IPMN). If lesions are detected, physicians can follow up with more extensive testing through endoscopic ultrasound or traditional (fine-needle aspiration) biopsy. If cancer is found, surgery may be recommended to remove part or all of the pancreas.
In addition to the registry, Memorial Sloan-Kettering epidemiologists are investigating risk factors for pancreatic cancer in patients and their family members and collecting DNA in an effort to identify genetic markers for the disease in relatives of patients with the disease.